North Dakota Society of Health-System Pharmacists

  • Home
  • January Journal Club Meeting

January Journal Club Meeting

  • 09 Jan 2024
  • 12:00 PM - 1:00 PM
  • Webinar, conference call

Registration

  • 0.1 CEU provided with this option This program is sponsored by the North Dakota Society of Health-System Pharmacists and was initially released December 13, 2016. Attendance at the session and completion of the evaluation form will be required to receive CE credit. Universal activity number: 0047-9999-16-037-L01-P
  • 0.1 CEU provided with this option This program is sponsored by the North Dakota Society of Health-System Pharmacists and was initially released December 13, 2016. Attendance at the session and completion of the evaluation form will be required to receive CE credit. Universal activity number: 0047-9999-16-037-L01-P
  • This option is perfect for anyone not needing CE credit, but are still participating and contributing to the meeting.

Registration is closed

What:   January Journal Club Meeting

Ciara Gonzales, PharmD

PGY1 Pharmacy Resident

Fargo VA Healthcare System

Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14;389(24):2221-2232.


Rebecca Aubart, PharmD

PGY1 Pharmacy Resident

Sanford Medical Center Fargo

Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023 Sep 21;389(12):1069-1084.


Cassidy Backowski, PharmD

PGY1 Pharmacy Resident

Fargo VA Healthcare System

Rosenstock J MD, Frias JP MD, Rodbard HW MD, et al. Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes the surpass-6 randomized clinical trial. JAMA. 2023 Oct 3; 330(17):1631-1640.


Moderator: 

John Sundsbak, PharmD

Trinity Health, Minot, ND 


Feedback Form:

https://forms.office.com/r/iFRCJh2y99


Semaglutide in Patients iwth HFpEF and obesity.pdf

jama_rosenstock_2023_oi_230119_1698789079.88265.pdf

Semaglutide and CV outcomes in Obesity wo DM Nov. 2023.pdf


Who: Pharmacy Personnel 

Where: Webinar/Teleconference


**************************************************************

NDSHP is inviting you to a scheduled Zoom meeting.


Topic: NDSHP Education/Networking Meeting

Join Zoom Meeting

https://zoom.us/j/99280627383


Meeting ID: 992 8062 7383

One tap mobile

+12532158782,,99280627383# US (Tacoma)

+13462487799,,99280627383# US (Houston)


Dial by your location

        +1 253 215 8782 US (Tacoma)

        +1 346 248 7799 US (Houston)

        +1 669 900 9128 US (San Jose)

        +1 301 715 8592 US (Germantown)

        +1 312 626 6799 US (Chicago)

        +1 646 558 8656 US (New York)

Meeting ID: 992 8062 7383


                  

NDSHP

Powered by Wild Apricot Membership Software